Interleukin-12 and tumor necrosis factor-α levels in cerebrospinal fluid of multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 147, Issue 2, 1997, Pages 145-150

  Drulović, Jelena ^a   Mostarica Stojković, Marija ^b   Lević, Zvonimir ^a   Stojsavljević, Nebojša ^a   Pravica, Vera ^b   Mesaroš, Šarlota ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cerebrospinal fluid; Interleukin 12; Multiple sclerosis; Tumor necrosis factor

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-12; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031569803     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)05320-8     Document Type: Article

References (42)

1. Aste-Amezaga, M., D'Andrea, A., Kubin, M. and Trinchieri, G. (1994) Co-operation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol., 156: 480-492.
2. Barten, D.M. and Ruddle, N.H. (1994) Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol., 51: 123-133.
3. Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H. and Wietzerbin, J. (1988) Increased production of interferon-γ and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand., 78: 318-323.
4. Cannella, B. and Raine, C.S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesion. Ann. Neurol., 37: 424-435.
5. Correale, J., Gilmore, W., McMillan, M., Li, S., McCarthy, K., Le, T. and Weiner, L.P. (1995) Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol., 154: 2959-2968.
6. Ebers, G.C. and Sadovnick, A.D. (1994) The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol., 54; 1-17.
7. Feuerstein, G.Z., Liu, T. and Barone, F.C. (1994) Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-α. Cerebrovasc. Brain Metab. Rev., 6: 341-360.
8. Germann, T. and Rude, E. (1995) Interleukin-12. Int. Arch. Allergy Immunol., 108: 103-112.
9. Hauser, S.L., Doolittle, T.H., Lincoln, R., Brown, R.H. and Dinarello, C.A. (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology, 40: 1735-1739.
10. Hendrzak, J.A. and Brunda, M. (1995) Biology of disease. Interleukin-12. Biologic activity, therapeutic utility, and role in disease. Lab. Invest., 72: 619-637.
11. Hohlfeld, R., Londei, M., Massacesi, L. and Salveti, M. (1995) T-cell autommunity in multiple sclerosis. Immunol. Today, 16: 259-261.
12. Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M., and Olsson, T. (1995) Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor-α and tumor necrosis factor-β. J. Neuroimmunol. 61: 205-212.
13. Kermode, A.G., Thompson, A.J., Tofts, P., MacManus, D.G., Kendal, B.E., Kingsley, D.P.E., Moseley, I.F., Rudge, P. and McDonald, W.I. (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain, 113: 1477-1489.
14. Kidd, D., Thompson, A.J., Kendal, B.E., Miller, D.H. and McDonald, W.I. (1994) Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity. J. Neurol. Neurosurg. Psychiatry, 57: 1070-1072.
15. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology. 33: 1444-1452.
16. Leonard, J.P., Waldburger, K.E. and Goldman, S.J. (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med., 181: 381-386.
17. Lightman, S., McDonald, W.I., Bird, A.C., Francis, D.A., Hoskins, A., Batchelor, J.R. and Halliday, A.M. (1987) Retinal venous sheathing in optic neuritis: its significance for the pathogenesis of multiple sclerosis. Brain, 110: 405-414.
18. Maimone, D., Gregory, S., Arnason, B.G.W. and Reder, A.T. (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol., 32: 67-14.
19. Manetti, R., Parronchi, P., Giudizi, M.G., Piccinni, M.P., Maggi, E., Trinchieri, G. and Romagnani, S. (1993) Natural killer cell stimulatory factor (interleukin-12) induces T helper I (Th1)-specific immune responses and inhibits the development of IL-4 producing cells. J. Exp. Med., 177: 1199-1204.
20. Moreau, T., Coles, A., Wing, M., Isaacs, J., Hale, G., Waldmann, H., and Compston, A. (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain, 119: 225-237.
21. Panitch, H.S., Haley, A.S., Hirsch, R.L. and Johnson, K.P. (1987) Exacerbations of multiple sclerosis in patients treated with γ-interferon. Lancet, 1: 893-895.
22. Pettinelli, C.B. and McFarlin, D.E. (1981) Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Eyt 1+2-T lymphocytes. J. Immunol., 127: 1420-1423.
23. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H., and Tourtellotte, W.W. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol., 13: 227-231.
24. Rentzos, M., Nikolaou, C., Rombos, A., Voumvourakis, K., Segditsa, I. and Papageorgiou, C. (1996) Tumor necrosis factor-α is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. J. Neurol., 243: 165-170.
25. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W. and Poser, S. (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 44: 1523-1526.
26. Rieckmann, P., Albrecht, M., Kitze, B., Weber. T., Tumani, H., Broocks, A., Luer, W., Helwig, A. and Poser, S. (1995) Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol., 37: 82-88.
27. Rott, O., Cash, E. and Fleischer, B. (1993) Phosphodiesterase inhibitor pentoxiphylline, a selective suppressor of T helper type 1 - but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol., 23: 1745-1751.
28. Selmaj, K.W. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol., 23: 339-346.
29. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, C.F. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest., 87: 949-954.
30. Selmaj, K., Raine, C.S. and Cross, A.H. (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol., 30: 694-700.
31. Sharief, M.K. and Hentges, R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. New Engl. J. Med., 325: 467-472.
32. Sun, D. (1991) Enhanced interferon-γ-induced 1a-antigen expression by glial cells after prevoius exposure to this cytokine. J. Neuroimmunol., 34: 205-214.
33. Traugott, U., Reinherz, E.L. and Raine, C.S. (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science, 219: 308-310.
34. Traugott, U. and Lebon, P. (1988) Interteron-γ and 1a antigen are present on astrocytes in active chronic multiple sclerosis lesions. J. Neurol. Sci., 84: 257-264.
35. Trembleau, S., Germann, T., Gately, M.K. and Adorini, L. (1995) The role of IL-12 in the induction of organ specific autoimmune diseases. Immunol. Today, 16: 383-386.
36. Trinchieri, G. (1993) Interleukin-12 and its role in generation of TH1 cells. Immunol. Today, 14: 335-337.
37. Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N. and Yone, K. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J. Neurol. Sci., 102: 230-234.
38. Tsukamoto, T., Ishikawa, M. and Yamamoto, T. (1995) Suppressive effects of TNF-α on myelin formation in vitro. Acta Neurol. Scand., 91: 71-75.
39. van der Pouw Kraan, T.C.T.M. Boeije, L.C.M., Smeenk, R.J.T., Wijdenes, J. and Aarden, L.A. (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med., 181: 775-779.
40. Waldburger, K.E., Hastings, R.C., Schaub, R.G., Goldman, S.J. and Leonard, J.P. (1996) Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12: preferential expansion of interferon-gamma producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am. J. Pathol., 148: 375-382.
41. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M.N., Cuzner, M.L. and Hafler, D.A. (1995) Expression of co-stimulatory molecules B7-1 (CD 80). B7-2 (CD 86), and interleukin-12 cytokine in multiple sclerosis lesions. J. Exp. Med., 182: 1985-1996.
42. Zipp, F., Weber, F., Huber, S., Sotgiu, S., Czlonkowska, A., Holler, E., Albert, E., Weiss, E.H., Wekerle, H. and Hohlfeld, R. (1995) Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-α by HLA-DR2+T cells. Ann. Neurol., 38: 723-730.